Molecular analysis of the region of distal 1p commonly deleted in neuroblastoma

Eur J Cancer. 1997 Oct;33(12):1957-61. doi: 10.1016/s0959-8049(97)00311-0.

Abstract

Cellular, cytogenetic, and molecular evidence indicates that chromosome band 1p36 is often deleted in neuroblastoma cell lines and tumours, suggesting the presence of one or more tumour suppressor genes in this region. We used a multifaceted approach to analyse the commonly deleted region, 28 distal 1p-specific polymorphic loci were used to detect loss of heterozygosity (LOH) in a panel of primary neuroblastoma tumours. Thirty-two of 122 tumours (26%) demonstrated LOH at three or more loci. In addition, a patient with a constitutional deletion of 1p36.2-.3 and two neuroblastoma cell lines with 1p36 abnormalities were characterised by FISH. When combined with the LOH data, a single consensus region of deletion was defined proximally by PLOD and distally by D1S80, a region spanning approximately five megabases. Several proposed candidate tumour suppressor genes, including ID3, CDC2L1, DAN, PAX7, E2F2, TNFR2 and TCEB3, map outside of this region; however, the transcription factor HKR3 cannot be excluded. LOH for 1p is correlated with adverse clinical and biological features and a poor prognosis, but 1p LOH is not an independent predictor of overall survival. To identify additional candidate genes, an integrated physical map of 1p35-36 is being constructed. The current map includes 445 polymerase chain reaction (PCR)-formatted markers and 608 YACs. This map will help identify region-specific transcripts by direct selection and sequencing.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Chromosome Deletion*
  • Chromosome Mapping
  • Chromosomes, Human, Pair 1 / genetics*
  • Consensus Sequence
  • Genes, Tumor Suppressor / genetics
  • Humans
  • In Situ Hybridization, Fluorescence
  • Loss of Heterozygosity / genetics
  • Multivariate Analysis
  • Neuroblastoma / genetics*
  • Prognosis
  • Proportional Hazards Models
  • Risk Factors
  • Tumor Cells, Cultured